These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 16796605)

  • 1. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
    Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
    Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
    Dickerman RD; McConathy WJ; Zachariah NY
    J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular side effects of anabolic-androgenic steroids].
    Kindermann W
    Herz; 2006 Sep; 31(6):566-73. PubMed ID: 17036188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a decrease in cardiovascular risk factors following recombinant growth hormone administration in abstinent anabolic-androgenic steroid users.
    Graham MR; Baker JS; Evans P; Kicman A; Cowan D; Hullin D; Davies B
    Growth Horm IGF Res; 2007 Jun; 17(3):201-9. PubMed ID: 17324600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders.
    Santos AM; da Rocha MS; da Silva MF
    Subst Use Misuse; 2011; 46(6):742-8. PubMed ID: 21114402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
    Bahrke MS; Yesalis CE
    Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic elastic properties in athletes using anabolic-androgenic steroids.
    Kasikcioglu E; Oflaz H; Arslan A; Topcu B; Kasikcioglu HA; Umman B; Bugra Z; Kayserilioglu A
    Int J Cardiol; 2007 Jan; 114(1):132-4. PubMed ID: 16364476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.
    Melnik B; Jansen T; Grabbe S
    J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal.
    Hartgens F; Kuipers H; Wijnen JA; Keizer HA
    Int J Sports Med; 1996 Aug; 17(6):429-33. PubMed ID: 8884417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of androgenic anabolic steroids before and during the Olympic Games: less but has not died out].
    de Ronde W
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1820-4. PubMed ID: 18783159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of anabolic steroids and strength training on the human immune response.
    Calabrese LH; Kleiner SM; Barna BP; Skibinski CI; Kirkendall DT; Lahita RG; Lombardo JA
    Med Sci Sports Exerc; 1989 Aug; 21(4):386-92. PubMed ID: 2674590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular implications of anabolic steroid abuse.
    Cheever K; House MA
    J Cardiovasc Nurs; 1992 Jan; 6(2):19-30. PubMed ID: 1729424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources.
    Santos MA; Oliveira CV; Silva AS
    Subst Use Misuse; 2014 Jul; 49(9):1132-7. PubMed ID: 24832723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM; Congeni JA
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgenic anabolic steroids and arterial structure and function in male bodybuilders.
    Sader MA; Griffiths KA; McCredie RJ; Handelsman DJ; Celermajer DS
    J Am Coll Cardiol; 2001 Jan; 37(1):224-30. PubMed ID: 11153743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use.
    Hurley BF; Seals DR; Hagberg JM; Goldberg AC; Ostrove SM; Holloszy JO; Wiest WG; Goldberg AP
    JAMA; 1984 Jul; 252(4):507-13. PubMed ID: 6737643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.
    Torrisi M; Pennisi G; Russo I; Amico F; Esposito M; Liberto A; Cocimano G; Salerno M; Li Rosi G; Di Nunno N; Montana A
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33158202
    [No Abstract]   [Full Text] [Related]  

  • 19. Side effects of anabolic androgenic steroids abuse.
    Bonetti A; Tirelli F; Catapano A; Dazzi D; Dei Cas A; Solito F; Ceda G; Reverberi C; Monica C; Pipitone S; Elia G; Spattini M; Magnati G
    Int J Sports Med; 2008 Aug; 29(8):679-87. PubMed ID: 18004690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgenic-anabolic steroids abuse in males.
    Di Luigi L; Romanelli F; Lenzi A
    J Endocrinol Invest; 2005; 28(3 Suppl):81-4. PubMed ID: 16042364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.